Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis

Yushuai Mi, Quanhui Li, Bingtian Liu, Dehai Wang, Ziping Liu, Tianshi Wang, Yuan Wang, Yifeng Zang, Yan Zhou, Yugang Wen, Yinlu DingGastric 2024 · DOI · OpenAlex

Abstract

This study identifies ubiquitous mitochondrial creatine kinase (uMtCK) as a pivotal driver of gastric cancer (GC) metastasis. By activating the JNK-MAPK/JUN signaling pathway, uMtCK upregulates Hexokinase 2 (HK2), thereby enhancing glycolytic flux and promoting aggressive cell migration and invasion. This article presents corrected figures for migration and invasion assays, reinforcing the role of the uMtCK/HK2 axis in GC progression and its impact on overall survival in animal models.

Introduction

Gastric cancer remains a leading cause of cancer-related mortality worldwide, largely due to its high metastatic potential. A hallmark of such aggressive cancers is "metabolic reprogramming," where cells alter their energy production—often favoring glycolysis even in the presence of oxygen (the Warburg effect)—to support rapid growth and movement. This research sought to understand the role of uMtCK, an enzyme typically involved in maintaining cellular ATP homeostasis, in this process. While uMtCK is known to function in the mitochondria, its specific contribution to the signaling pathways that regulate glycolysis and metastasis in gastric cancer was previously unclear.

Methodology

The authors employed a combination of in vitro and in vivo techniques to map the uMtCK signaling axis. The study utilized two gastric cancer cell lines, AGS and SGC-7901. Genetic manipulation was achieved using lentiviral vectors for overexpression (Lv-uMtCK) and small interfering RNA (si-uMtCK) or short hairpin RNA (sh-HK2) for gene knockdown. Functional assays included wound-healing assays to measure collective cell migration and Transwell migration and invasion assays to quantify individual cell movement. In vivo metastasis was modeled by injecting engineered GC cells into the spleens of nude mice, with progression monitored via bioluminescence imaging and histological analysis of liver tissues.

Key Results

uMtCK as a Metastatic Driver

The study's most critical insight is that uMtCK is a proactive driver of metastasis. Overexpressing uMtCK significantly increased the number of migrated and invasive cells, while knocking it down had the opposite effect. In AGS cells, uMtCK overexpression nearly doubled the percentage of wound closure and significantly increased the number of invaded cells compared to controls.

Figure 2: Comprehensive analysis of uMtCK's role in GC progression, including wound healing (a-b), transwell assays (c-d), in vivo metastasis (e), histology (f), and survival (g).

In Vivo Metastasis and Survival

In the mouse model, cells overexpressing uMtCK formed significantly more metastatic lesions in the liver. Conversely, uMtCK knockdown (si-uMtCK) drastically reduced the metastatic burden. Mice injected with uMtCK-overexpressing cells showed significantly shorter overall survival (OS) compared to the control group.

Figure 2e: Bioluminescence imaging of nude mice showing liver metastasis in different experimental groups (Vector, Lv-uMtCK, Scramble, si-uMtCK).

The HK2 Dependency and Signaling Bridge

The researchers identified the JNK-MAPK/JUN axis as the bridge between mitochondrial enzyme activity (uMtCK) and nuclear transcriptional control of glycolytic enzymes (HK2). The pro-metastatic effects of uMtCK were found to be strictly dependent on Hexokinase 2 (HK2). Inhibition of migration and invasion caused by uMtCK knockdown could be "rescued" (reversed) by overexpressing HK2, confirming HK2's role as the primary downstream effector.

Conclusion

This study establishes the uMtCK/JNK-MAPK/JUN/HK2 axis as a significant metabolic driver of gastric cancer progression. By connecting mitochondrial metabolism directly to signaling pathways that dictate cell behavior, the findings suggest that targeting this axis could be a viable therapeutic strategy. The corrected figures provided in this notice support the original conclusions and clarify the experimental evidence for migration and invasion assays.

Summary updated

Abstract

In this article, the scramble group of the invasion experiment in Fig. 2d, the Vector group of the migration experiment in Fig. 6c, the si-uMtCK + Lv-HK2 group of the invasion experiment in Fig. 6d and the experimental results of Lv-uMtCK + sh-HK2 in Fig. 6e were erroneously published; the Figs. 2 and6 should have appeared as shown below.
BibTeX
@inproceedings{mi2024correction,
  author = {Yushuai Mi and Quanhui Li and Bingtian Liu and Dehai Wang and Ziping Liu and Tianshi Wang and Yuan Wang and Yifeng Zang and Yan Zhou and Yugang Wen and Yinlu Ding},
  title = {{Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis}},
  booktitle = {Gastric},
  year = {2024},
  doi = {10.1007/s10120-024-01490-w},
}
Figure